References
1) Carapetis JR, McDonald M, Wilson NJ (2005) Acute rheumatic fever. Lancet 366: 155-168.
2) Carapetis JR, Steer AC, Mulholland EK, Weber M (2005) The global burden of group A streptococcal diseases. Lancet Infect Dis 5:685-694.
3) Rheumatic fever and rheumatic heart disease: report of a WHO Expert consultation, Geneva, 29 October–1 November 2001. Geneva: World Health Organization, 2004.
4) Australian Institute of Health and Welfare (2004) Rheumatic heart disease: all but forgotten in Australia except among Aboriginals and Torres Strait Islander Peoples, Australian Institute of Health and Welfare, Canberra 2004.
5) Australian Institute of Health and Welfare (2005) The health and welfare of Australia’s Aboriginal and Torres Strait Islander Peoples, Australian Institute of Health and Welfare, Canberra 2005.
6) Gruen RL, Bailie RS, d’Abbs PH, O’Rourke IC, O’Brien MM, Verma N (2001) Improving access to specialist care for remote Aboriginal communities: evaluation of a specialist outreach service, Med J Aust 174 (10): 507–511.
7) Salustri A, Trambaiolo P (2002) Point-of-care echocardiography: small, smart and quick, Eur Heart J 23 (19): 1484–1487.
8) Carapetis JR, Powers JR, Currie BJ, Sangster JF, Begg A, Fisher DA, Kilburn CJ, Burrow JNC (2000) Outcomes of cardiac valve replacement for rheumatic heart disease in Aboriginal Australians, Asia Pacific Heart J 8 (3):138–147.
9) Gill JM, Landis MK (2002) Benefits of a mobile, point-of-care anticoagulation therapy management program, Jt Comm J Qual Improv 28 (11): 625–630.
10) Reményi B, Wilson N, Steer A, Ferreira B, Kado J, Kumar K, Lawrenson J, Maguire G, Marijon E, Mirabel M, Mocumbi AO (2012) World Heart Federation criteria for echocardiographic diagnosis of rheumatic heart disease–an evidence-based guideline. Nat Rev Cardiol 9: 297–309.
11) Marijon E, Celermajer DS, Tafflet M, El-Haou S, Jani DN, Ferreira B, Mocumbi AO, Paquet C, Sidi D, Jouven X (2009) Rheumatic heart disease screening by echocardiography: The inadequacy of world health organization criteria for optimizing the diagnosis of subclinical disease. Circulation 120(8): 663–668.
12) El Aroussy WA, ElHagracy N, Fawzi H, Zaher S, Taha N, Moustafa S (2014). Prevalence of Rheumatic Valvular Heart Disease Among Egyptian School Children. Echocardiographic and Doppler Screening. Global Heart 9(1): 299.
13) Gemechu T, Mahmoud H, Parry EH, Phillips DI, Yacoub MH (2017) Community-based prevalence study of rheumatic heart disease in rural Ethiopia. European journal of preventive cardiology 24(7):717-723.
14) Jaffe WM, Roche AH, Coverdale HA, McAlister HF, Ormiston JA, Greene ER (1988) Clinical evaluation versus Doppler echocardiography in the quantitative assessment of valvular heart disease. Circulation 78(2):267-275.